[1] |
National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association.
Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association
[J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
|
[2] |
Ren Yufei, Chen Xiaoqing, Kong Weizong, et al..
Effect of salvianolic acid B on autophagy in nonalcoholic fatty liver disease cell model in vitro
[J]. Journal of Practical Hepatology, 2019, 22(6): 804-807.
|
[3] |
Gao Lei, Cao Lei, Wang Ruifang, et al..
Protective effect of human umbilical cord mesenchymal stem cell transplantation on alcoholic liver injury in rats
[J]. Journal of Practical Hepatology, 2019, 22(6): 812-815.
|
[4] |
chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al..
Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with
[J]. Journal of Practical Hepatology, 2019, 22(6): 816-819.
|
[5] |
Shi Yingying, Wang Yuanxi..
Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 820-823.
|
[6] |
Min Feng, Huang Wenqi, Wu Weibing, et al..
Implications of serum adipocytokine levels in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
|
[7] |
patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al..
Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in
[J]. Journal of Practical Hepatology, 2019, 22(6): 828-831.
|
[8] |
chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin..
Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in
[J]. Journal of Practical Hepatology, 2019, 22(6): 832-835.
|
[9] |
Ma Liying, Shen Lijuan..
Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads
[J]. Journal of Practical Hepatology, 2019, 22(6): 836-839.
|
[10] |
Pan Meimin, Li Wenjuan, Jiang Fangqing, et al..
Changes of serum IL-17A,fibroblast growth factor and IL-7 levels in patients with hepatitis C virus infection
[J]. Journal of Practical Hepatology, 2019, 22(6): 840-843.
|
[11] |
Li Yingyi, Guo Cuifen, Zhang Ruinan, et al..
Correlation of polymorphism of ALDH2 rs671 to morbidity in individuals prone to nonalcoholic fatty liver disease
[J]. Journal of Practical Hepatology, 2019, 22(6): 848-851.
|
[12] |
Xing Xin, Wei Zhongcao, Zhou mimi, et al..
Efficacy and safety of tauroursodeoxycholic acid and ursodeoxycholic acid combination in the treatment of patients with nonalcoholic fatty liver disease:a Meta-analysis
[J]. Journal of Practical Hepatology, 2019, 22(6): 852-855.
|
[13] |
Yang Caiyong, Chen Na, Li Kui, et al..
Clinical significance of peripheral blood Treg and Th17 cells in patients with chronic hepatitis C and hepatitis C-induced liver cirrhosis
[J]. Journal of Practical Hepatology, 2019, 22(6): 868-871.
|
[14] |
Zhu Yage, Liu Jinfeng..
Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels
[J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
|
[15] |
Li Chuanjie, Xu Jing, Wang Liangliang, et al..
Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment
[J]. Journal of Practical Hepatology, 2019, 22(6): 928-929.
|